-
Panel Discussion
-
Drug Development for Anxiety Disorders: New Roles for Atypical Antipsychotics
By William H. Carson, MD, Hisashi Kitagawa, PhD, and Charles B. Nemeroff, MD, PhD
-
Unmet Needs in the Treatment of Anxiety Disorders
By Mark H. Pollack, MD
-
Late-Life Anxiety Disorders
By Carl Salzman, MD
-
Understanding Psychiatric Disorders Through Functional Brain Imaging
By Clinton D. Kilts, PhD
-
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
By Charles B. Nemeroff, MD, PhD
-
Studying Non-Human Primates: A Gateway to Understanding Anxiety Disorders
By Ned H. Kalin, MD
-
Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics
By Charles B. Nemeroff, MD, PhD
-
-
FEATURE ARTICLE
Understanding The Fibromyalgia Syndrome
Srinivas G. Rao, MD, PhD, Judith F. Gendreau, MD, and Jay D. Kranzler, MD, PhD
-
Valproate Use in Neuropsychiatric Disorders in the Elderly
By Pierre N. Tariot, MD
-
Divalproex in the Treatment of Migraine
By Frederick G. Freitag, DO
-
The Use of Divalproex in the Treatment of Addictive Disorders
By Hugh Myrick, MD and Kathleen T. Brady, MD, PhD
-
Schizophrenia and Valproate
By Leslie Citrome, MD, MPH
